NSE / BSEHealthcare
₹356.70+5.45+1.55%
P/E27.0Mkt Cap₹6.39 K CrEV/EBITDA14.2

FDC Ltd.

P/E27.0Mkt Cap₹6.39 K CrEV/EBITDA14.2
Company Profile

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.

Valuation

Market Cap
₹0.00
Current Price
₹0
as of 16 Oct 2026
P/E Ratio
0.0x
P/B Ratio
0.0x
EV / EBITDA
0.0x
EV / Sales
0.0x
52W High
₹0
52W Low
₹0
Shares Out
0.00 Cr

Profitability

Operating Margin
0.0%
Net Profit Margin
0.0%
EBITDA Margin
0.0%

Returns

ROE
0.0%
ROCE
0.0%
ROIC %
—
ROA
0.0%
Dividend Payout
0.0%

Solvency

Current Ratio
0.0x
Debt / Equity
0.0x
Debt / Assets
0.0x
CFO / Net Profit
0.0x
Interest Coverage
0.0x

AI Summary

Indian Stock

Strengths1

  • Comfortable interest coverage of 84.5x

Concerns0

    Rule-based from financial data. Not advice.

    Price History▼ 18.14% over 1Y

    Monthly Returns

    Unlock Monthly Returns

    Available on Pro and Institutional plans.

    Sign up free

    Year-to-Date ROI

    Unlock Year-to-Date ROI

    Available on Pro and Institutional plans.

    Sign up free

    Historical Volatility

    Unlock Historical Volatility

    Available on Pro and Institutional plans.

    Sign up free

    Historical Performance

    Revenue, profitability, and cash flow trends (₹ Crores)

    Revenue (10Y)

    Operating Income (10Y)

    Net Profit (10Y)

    Operating Margin % (10Y)

    Dividend Payout % (10Y)

    Free Cash Flow (10Y)

    Growth Summary

    Latest fiscal year: Mar 2025

    Revenue₹2.07 K Cr▲ 8.0%
    EBITDA Growth—
    Net Profit₹274.00 Cr▼ 10.7%
    Cash from Ops (CFO)—
    Free Cash Flow (FCF)—▲ 1800.0%
    Revenue CAGR 5Y7.6%
    EBITDA CAGR 5Y3.8%
    Net Profit CAGR 5Y4.4%
    NP Growth 1Y-10.7%

    Historical Growth

    Year-by-year revenue, profitability, and cash flow (₹ Crores, last 1 year)

    YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
    Mar 2025₹2.07 K Cr—₹274.00 Cr——12.0%8.0%-10.7%

    Showing the latest year only. Sign up free for the full history.

    Financial Statements

    Income statement, balance sheet, and cash flow (₹ Crores, as reported)

    Showing the latest year only. Sign up free for the full history.

    Consolidated Figures in USD Millions.

    Unnamed: 0TTM
    Revenue / Net Sales2,045
    Total Expenses1,770
    EBIT / Operating Profit275
    OPM %13%
    Other Income107
    Finance Costs4
    Depreciation & Amortisation59
    Profit Before Tax318
    Tax %-
    Net Profit / PAT236
    EPS (₹)14.52
    Dividend Payout %-

    Peer Comparison

    Healthcare sector peers, ranked by market cap

    CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
    FDC Ltd.this co.₹6.39 K Cr₹2.07 K Cr27.002.6114.228.0%
    Sun Pharmaceutical Industries Ltd.₹4.15 L Cr₹23.00 K Cr88.7017.4372.3013.5%
    Divi's Laboratories Ltd.₹1.71 L Cr₹9.20 K Cr67.9011.1367.2120.0%
    Torrent Pharmaceuticals Ltd.₹1.33 L Cr₹9.68 K Cr62.5015.7645.6413.5%
    Cipla Ltd.₹1.17 L Cr₹19.05 K Cr22.503.5119.3314.9%
    Apollo Hospitals Enterprises Ltd.₹1.05 L Cr₹8.20 K Cr75.0011.2854.4412.8%
    Max Healthcare Institute Limited₹1.00 L Cr₹2.66 K Cr144.0011.7696.8413.8%
    Industry Average—₹3.29 K Cr98.638.1165.5020.2%

    Learn while you research

    Hand-picked academy chapters to deepen your understanding of FDC Ltd. and the metrics that matter.

    Browse the full Equiscale Academy